Galapagos | Kostnadene For Salg



Cost Of Sales Endring Dato
argenx SE USD 72.66M 222.35M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Biogen USD 583.5M 55.2M 2024-12
Genmab DKK 337M 64M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Incyte USD 82.38M 2.49M 2024-12
Merck EUR 2.32B 197M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
UCB EUR 425.5M 479.5M 2024-06
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Galapagos Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.